Short, unregulated hit pieces are getting some pharmaceutical executives worried:
These budding Michael Moores are a worry to the industry “because there are no internal controls on YouTube,” says Dorothy Wetzel, former consumer-marketing chief at Pfizer and now senior VP-management supervisor at Saatchi & Saatchi, New York, where she works on AstraZeneca accounts. “But,” she added, “you have to get used to it, because it’s here to stay.”
(via PharmaGossip)
